The beta-thalassemias are a heterogeneous group with respect to molecu
lar pathogenesis, and different populations and ethnic groups differ w
ith respect to the predominating mutations. This variable spectrum of
beta-thalassemia mutations has resulted in extensive studies in each p
opulation and ethnic group to identify the major mutations. In this st
udy we investigated the prevalence of 14 mutations in 253 beta-thalass
emia patients drawn from eight Arab countries (i.e. Jordan, Egypt, Syr
ia, Lebanon, Yemen, and Saudi Arabia), living in Saudi Arabia and atte
nding Ministry of Health hospitals. The mutations investigated include
d IVS-I-110 (G-->A), IVS-II-1 (G-->A), IVS-I-5 (G-->C), codon 39 (C-->
T), IVS-I-1 (G-->A), frameshift at codons 8/9 (+G), frameshift at codo
ns 41/42 (-TTCT), codon 15 (T (G) under bar G-->T (A) under bar G), IV
S-I-6 (T-->C), frameshift at codon 16 (-C), IVS-II-745 (C-->G), codon
6 (-A), IVS-I, 3' end (-25 bp), and Cap +1 (A-->C). The most frequentl
y encountered mutations were IVS-I-110 and IVS-II-1 which were identif
ied in the population of each Arab country. The IVS-I-1 and IVS-II-745
mutations were encountered in Jordanians, Egyptians, and Syrians. The
IVS-I-5, codon 39, codon 6, IVS-I, 3' end (-25 bp), and Cap +1 mutati
ons were encountered only in Saudis and not in other Arabs, except cod
on 39 which was present in the Syrians and Lebanese. Other mutations w
ere generally rare and not specific to any Arab ethnic group. This pap
er presents preliminary data on the prevalence of 14 mutations in the
Arab populations and shows wide variation in the molecular basis of be
ta-thalassemia in different Arab ethnic groups. Further detailed studi
es to identify the entire spectrum of beta-thalassemia mutations are s
tressed.